Paras Healthcare IPO 2026 GMP, Price, Dates & Review

The healthcare sector in India has attracted attention as demand for quality medical treatment continues to grow. Hospitals offering specialised services, modern facilities and experienced medical professionals play an important role in meeting this demand. Paras Healthcare is one of the companies operating in this space, and its upcoming public offering is drawing interest from IPO investors.

In this article for NewIPO.info, we look at the Paras Healthcare IPO, including its business model, IPO dates, price band, issue size, Grey Market Premium (GMP), financial considerations and important risks investors should understand before applying.

Paras Healthcare IPO Overview

Paras Healthcare Limited operates hospitals under the Paras Health brand. The company provides specialised healthcare services across several medical fields, including cardiac care, cancer treatment, neurosciences, orthopaedics and renal sciences.

According to available IPO information, the company operates eight hospitals across five states and one Union Territory. Its hospital network includes locations such as Gurugram, Panchkula, Patna, Darbhanga, Kanpur, Udaipur, Ranchi and Srinagar.

Here are the key details of the Paras Healthcare IPO.

IPO details are based on available published information and may be subject to official updates.

About Paras Healthcare Limited

Paras Healthcare focuses on providing specialised medical services through its hospital network. Rather than operating only as a general healthcare provider, the company offers treatment across several clinical specialities that often require advanced equipment, experienced doctors and dedicated medical teams.

The company serves patients in multiple regions of India. Its presence in cities across northern, eastern and western India allows it to reach different patient populations and develop its hospital operations across several markets.

The healthcare business also requires continuous investment in medical equipment, hospital infrastructure, trained staff and technology. These factors can support long-term growth, but they also create substantial operating expenses. Investors should therefore consider both the company's expansion opportunities and its ability to manage costs efficiently.

Paras Healthcare Limited was incorporated in 1987 and operates a network of eight hospitals with an aggregate bed capacity of 2,211 beds as of June 30, 2026, across five states and one union territory in North India, Bihar and Jharkhand under the 'Paras Health' brand.

The company is a clinical specialty-led hospital platform focused on tertiary and quaternary care, with deep capabilities across cardiac sciences, oncology, neuro sciences, gastro sciences, orthopedics and renal sciences (collectively, CONGOR), which together contributed over 70% of revenue from operations in recent periods.

Its hospitals are located in Gurugram and Panchkula (Haryana), Patna and Darbhanga (Bihar), Kanpur (Uttar Pradesh), Udaipur (Rajasthan), Ranchi (Jharkhand) and Srinagar (Jammu and Kashmir), operated through a mix of owned, leased, revenue-share and public-private partnership models.

The company has a committed expansion pipeline, including new hospitals planned in Gurugram and Ludhiana, and aims to increase its total bed capacity to over 3,000 beds by March 2028.

Paras Healthcare continues to strengthen its clinical infrastructure, digital ecosystem and specialty programs to support its growth strategy across North India and the eastern region.

Strengths

Largest Healthcare Provider with First-Mover Advantage: The company is one of the largest healthcare providers in North India, Bihar and Jharkhand by bed capacity, with 2,211 beds across eight hospitals as of June 30, 2026, several of which were first corporate hospital entrants in their respective markets.

Strong Focus on Tertiary and Quaternary Care: CONGOR specialties, comprising cardiac, oncology, neuro, gastro, orthopedics and renal sciences, accounted for 74.70%, 71.92% and 72.34% of revenue from operations in Fiscals 2026, 2025 and 2024, respectively, supported by dedicated ICU infrastructure and transplant programs.

Capital-Efficient and Flexible Operating Model: The company operates hospitals through a mix of owned, leased, revenue-share and public-private partnership structures, enabling disciplined, capital-efficient expansion with a capital expenditure per bed of ₹7.70 million as of June 30, 2026.

Risk Factors

History of Losses: The company incurred consolidated losses of ₹(10.24) million, ₹(579.83) million and ₹(153.31) million in the three months ended June 30, 2025 and Fiscals 2025 and 2024, respectively, and there is no assurance that profitability achieved in Fiscal 2026 will continue.

Subsidiary Losses: Subsidiaries PHRPL and PMHPL together incurred losses of ₹(203.82) million, ₹(520.89) million, ₹(822.38) million and ₹(872.69) million in the three months ended June 30, 2025 and Fiscals 2026, 2025 and 2024, as their hospitals continue to scale up operations.

High Attrition Among Healthcare Staff: The company experienced attrition rates of 12.01%, 16.09%, 60.38%, 66.74% and 65.27% among doctors, nurses and other staff in the relevant periods, and failure to manage attrition could adversely affect service quality and operations.

Paras Healthcare IPO Dates

The IPO is scheduled to open for subscription on 21 October 2026 and close on 23 October 2026.

The tentative allotment date is 26 October 2026, while refunds and share credits are expected to be processed around 27 October 2026. The shares are scheduled to list on the stock exchanges on 28 October 2026.

Investors should confirm the final schedule through the official IPO documents and exchange announcements before taking any action.

Paras Healthcare IPO Price Band and Lot Size

The price band for the Paras Healthcare IPO is ₹660 to ₹693 per share. The minimum application lot consists of 21 shares.

At the lower end of the price band, an application for one lot requires ₹13,860. At the upper end, the investment amount is ₹14,553.

Retail investors should calculate their application amount using the final offer price and the applicable application rules. Applying for an IPO does not guarantee that shares will be allotted.

Paras Healthcare IPO Issue Size and Objectives

The company plans to raise approximately ₹1,450 crore through its public offering. The issue comprises a fresh issue of ₹500 crore and an Offer for Sale of ₹950 crore.

The fresh issue will provide funds to the company. Based on published IPO information, a portion of these proceeds is intended for debt repayment, investment in a subsidiary and general corporate purposes.

The Offer for Sale allows existing shareholders to sell some of their shares. The proceeds from this portion generally go to the selling shareholders rather than directly to the company.

Investors should read the Red Herring Prospectus (RHP) to understand the precise allocation of funds and the financial implications of the offer.

Paras Healthcare IPO GMP Today

The Grey Market Premium, commonly called GMP, is an unofficial indicator that some market participants use to assess interest in an IPO before its listing.

The Paras Healthcare IPO GMP may change daily depending on investor sentiment, subscription demand, market conditions and expectations about the company's valuation.

It is important to understand that GMP is not an official figure published or guaranteed by NSE, BSE or SEBI. It is also not a reliable promise of listing gains.

For the latest available GMP, investors should check the date and source of the reported figure on the IPO GMP Today page at NewIPO.info. Any estimated listing price based on GMP should be treated as speculative.

Why Is Paras Healthcare Attracting Investor Attention?

1. Presence in the Healthcare Sector

Healthcare services are essential, and demand for specialised treatment may create opportunities for established hospital operators. However, industry growth does not automatically translate into higher profits for every company.

2. Specialised Medical Services

Paras Healthcare operates across multiple clinical specialities. A diversified range of medical services can help a hospital network serve different patient needs, although performance depends on patient volumes, treatment costs and operational efficiency.

3. Hospital Network

The company's presence in several cities provides a platform for serving different regional markets. Investors should also consider how efficiently each hospital operates and whether future expansion can generate adequate returns.

4. Use of Fresh Issue Proceeds

The proposed fresh issue includes funds intended for debt repayment and other corporate requirements. Reducing debt may help ease interest expenses, but investors should assess the company's overall borrowing levels and cash flows before drawing conclusions.

Important Risks to Consider

Every IPO carries risks, and investors should not make a decision based only on a company's sector or popularity.

Valuation risk: The offer price should be evaluated against the company's earnings, debt, cash flow and comparable listed hospital businesses.

Operational costs: Hospitals require significant spending on doctors, nurses, equipment, facilities and maintenance. Rising costs can affect profitability.

Competition: Healthcare providers compete on treatment quality, reputation, medical talent, pricing and access to specialised facilities.

Expansion risk: New hospitals and upgrades may require substantial investment and time before reaching sustainable operating performance.

Debt and cash flow: Investors should examine outstanding borrowings, interest expenses, cash generation and the intended use of IPO proceeds.

GMP uncertainty: A positive grey market premium does not guarantee a profitable listing. Market conditions can change before the shares begin trading.

Should You Apply for the Paras Healthcare IPO?

There is no single answer that suits every investor. A careful decision should begin with the company's financial statements, valuation, business outlook, debt position and use of IPO proceeds.

Investors may also compare its valuation with other listed hospital operators and consider whether the proposed offer price leaves room for reasonable long-term returns.

Those interested only in short-term listing gains should be particularly cautious about relying on GMP or subscription figures. Investors with a longer horizon should focus on the company's ability to generate sustainable earnings and cash flows.

Read the official RHP and understand the risks before submitting an application. An IPO application should fit your financial goals and risk tolerance rather than being driven by market excitement.

Frequently Asked Questions (FAQs)

1. What is the Paras Healthcare IPO opening date?

The IPO is scheduled to open on 21 October 2026 and close on 23 October 2026.

2. What is the Paras Healthcare IPO price band?

The announced price band is ₹660 to ₹693 per share.

3. What is the lot size of the Paras Healthcare IPO?

The minimum lot size is 21 shares.

4. What is the minimum investment required?

The minimum investment is ₹13,860 at the lower price band and ₹14,553 at the upper price band for one lot.

5. What is the Paras Healthcare IPO GMP?

GMP refers to the unofficial premium at which IPO shares may be discussed or traded in the grey market before listing. It fluctuates and does not guarantee listing performance.

6. When is the Paras Healthcare IPO allotment expected?

The tentative allotment date is 26 October 2026.

7. When is the Paras Healthcare IPO listing date?

The tentative listing date is 28 October 2026 on NSE and BSE.

8. Is the Paras Healthcare IPO a good investment?

That depends on the company's financial performance, valuation, growth prospects and risks, as well as the investor's objectives. Investors should review the official offer document before deciding.

Conclusion

The Paras Healthcare IPO gives investors an opportunity to evaluate a hospital operator with a presence across several Indian markets and a range of specialised medical services. Its business model may offer growth opportunities, but hospital operations also involve high costs, competitive pressure and significant capital requirements.

Before applying, investors should examine the issue price, financial results, debt position, IPO objectives and valuation. GMP can provide a glimpse of unofficial market sentiment, but it should never replace proper research.

For more information on upcoming IPOs in India, IPO GMP Today, subscription updates and allotment status, visit NewIPO.info and review the latest available information before making an investment decision.

Disclaimer: This article is for educational and informational purposes only. It is not investment advice or a recommendation to buy or sell any security. IPO details may change; please verify them using official exchange announcements and the company's offer documents.